Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Varicella zoster virus infection.

Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K.

Nat Rev Dis Primers. 2015 Jul 2;1:15016. doi: 10.1038/nrdp.2015.16.

PMID:
27188665
2.

Long-term persistence of zoster vaccine efficacy.

Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH, Looney DJ, Betts R, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman CA, Marques A, Toney J, Boardman K, Su SC, Li X, Chan IS, Parrino J, Annunziato P, Oxman MN; Shingles Prevention Study Group.

Clin Infect Dis. 2015 Mar 15;60(6):900-9. doi: 10.1093/cid/ciu918. Epub 2014 Nov 20.

3.

Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations.

Oxman MN, Schmader KE.

Clin Infect Dis. 2014 Oct;59(7):920-2. doi: 10.1093/cid/ciu501. Epub 2014 Aug 4. No abstract available.

4.

Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults.

Lee E, Cho HJ, Olmstead R, Levin MJ, Oxman MN, Irwin MR.

Sleep. 2013 Nov 1;36(11):1685-91. doi: 10.5665/sleep.3128.

5.

Safety of zoster vaccine in elderly adults following documented herpes zoster.

Morrison VA, Oxman MN, Levin MJ, Schmader KE, Guatelli JC, Betts RF, Gelb LD, Pachucki CT, Keay SK, Menzies B, Griffin MR, Kauffman CA, Marques AR, Toney JF, Simberkoff MS, Serrao R, Arbeit RD, Gnann JW, Greenberg RN, Holodniy M, Keitel WA, Yeh SS, Davis LE, Crawford GE, Neuzil KM, Johnson GR, Zhang JH, Harbecke R, Chan IS, Keller PM, Williams HM, Boardman KD, Silber JL, Annunziato PW; Shingles Prevention Study Group.

J Infect Dis. 2013 Aug 15;208(4):559-63. doi: 10.1093/infdis/jit182. Epub 2013 Apr 30.

6.

Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.

Irwin MR, Levin MJ, Laudenslager ML, Olmstead R, Lucko A, Lang N, Carrillo C, Stanley HA, Caulfield MJ, Weinberg A, Chan IS, Clair J, Smith JG, Marchese RD, Williams HM, Beck DJ, McCook PT, Zhang JH, Johnson G, Oxman MN.

Clin Infect Dis. 2013 Apr;56(8):1085-93. doi: 10.1093/cid/cis1208. Epub 2013 Feb 13.

7.

Vaccination against herpes zoster in developed countries: state of the evidence.

Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M.

Hum Vaccin Immunother. 2013 May;9(5):1177-84. doi: 10.4161/hv.23491. Epub 2013 Jan 16. Review.

8.

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.

Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, Morrison VA, Gelb L, Guatelli JC, Harbecke R, Pachucki C, Keay S, Menzies B, Griffin MR, Kauffman C, Marques A, Toney J, Keller PM, Li X, Chan IS, Annunziato P; Shingles Prevention Study Group.

Clin Infect Dis. 2012 Nov 15;55(10):1320-8. doi: 10.1093/cid/cis638. Epub 2012 Jul 24.

9.

Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study.

Drolet M, Levin MJ, Schmader KE, Johnson R, Oxman MN, Patrick D, Fournier SO, Mansi JA, Brisson M.

Vaccine. 2012 Mar 9;30(12):2047-50. doi: 10.1016/j.vaccine.2012.01.045. Epub 2012 Jan 28.

PMID:
22285632
10.

Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources.

Benbernou A, Drolet M, Levin MJ, Schmader KE, Oxman MN, Johnson R, Patrick D, Camden S, Mansi JA, Brisson M.

Eur J Pain. 2011 Nov;15(10):1100-6. doi: 10.1016/j.ejpain.2011.04.014. Epub 2011 May 19.

PMID:
21600819
11.

Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.

Oxman MN, Gershon AA, Poland GA.

Vaccine. 2011 May 9;29(20):3625-7. doi: 10.1016/j.vaccine.2011.04.019. No abstract available.

PMID:
21524565
12.

Major depressive disorder and immunity to varicella-zoster virus in the elderly.

Irwin MR, Levin MJ, Carrillo C, Olmstead R, Lucko A, Lang N, Caulfield MJ, Weinberg A, Chan IS, Clair J, Smith JG, Marchese RD, Williams HM, Beck DJ, McCook PT, Johnson G, Oxman MN.

Brain Behav Immun. 2011 May;25(4):759-66. doi: 10.1016/j.bbi.2011.02.001. Epub 2011 Feb 15.

13.

The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.

Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA.

CMAJ. 2010 Nov 9;182(16):1731-6. doi: 10.1503/cmaj.091711. Epub 2010 Oct 4.

14.

Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults.

Schmader KE, Johnson GR, Saddier P, Ciarleglio M, Wang WW, Zhang JH, Chan IS, Yeh SS, Levin MJ, Harbecke RM, Oxman MN; Shingles Prevention Study Group.

J Am Geriatr Soc. 2010 Sep;58(9):1634-41. doi: 10.1111/j.1532-5415.2010.03021.x.

15.

A prospective study of the herpes zoster severity of illness.

Drolet M, Brisson M, Levin MJ, Schmader KE, Oxman MN, Johnson RW, Camden S, Mansi JA.

Clin J Pain. 2010 Oct;26(8):656-66. doi: 10.1097/AJP.0b013e3181eef686.

PMID:
20842005
16.

Zoster vaccine: current status and future prospects.

Oxman MN.

Clin Infect Dis. 2010 Jul 15;51(2):197-213. doi: 10.1086/653605. Review.

17.

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.

Simberkoff MS, Arbeit RD, Johnson GR, Oxman MN, Boardman KD, Williams HM, Levin MJ, Schmader KE, Gelb LD, Keay S, Neuzil K, Greenberg RN, Griffin MR, Davis LE, Morrison VA, Annunziato PW; Shingles Prevention Study Group.

Ann Intern Med. 2010 May 4;152(9):545-54. doi: 10.7326/0003-4819-152-9-201005040-00004.

PMID:
20439572
18.

Prior depression history and deterioration of physical health in community-dwelling older adults--a prospective cohort study.

Cho HJ, Lavretsky H, Olmstead R, Levin M, Oxman MN, Irwin MR.

Am J Geriatr Psychiatry. 2010 May;18(5):442-51. doi: 10.1097/JGP.0b013e3181ca3a2d.

19.

Immune response to a refrigerator-stable zoster vaccine.

Levin MJ, Oxman MN, Johnson GR, Zhang JH, Hayward AR, Weinberg A.

Clin Vaccine Immunol. 2009 Sep;16(9):1381; author reply 1381-2. doi: 10.1128/CVI.00338-08. No abstract available.

20.

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schödel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ; US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2009 Oct 1;200(7):1068-77. doi: 10.1086/605611.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk